Situation Report of MPOX in Global and ASEAN Region - 6 July 2023

Global Update

• Worldwide, over 691 million cases and over 6 million deaths have been attributed to COVID-19.

Vaccine Update

• Moderna has signed a memorandum of understanding and land collaboration agreement with Shanghai's city government to research, develop, and manufacture mRNA medicines in China v (CNA, 2023). The medicines produced under the agreement will be exclusively for the Chinese people and will not be exported. The city government confirmed the signing of strategic cooperation agreements with Moderna, with authorities including Shanghai's Communist Party Secretary Chen Jining meeting with the company's CEO Stephane Bancel. Moderna is set to make its first investment in China, potentially worth around $1 billion. The company's expansion into mainland China comes as revenue growth slows due to waning global demand for its COVID-19 vaccine. Moderna forecasted a possible net loss for 2023, but has been kept out of selling its mRNA vaccine to China due to Beijing's insistence on using only Chinese-made COVID-19 vaccines for its population.